Pot Co. Tilray Hit With Securities Suit After $321M Net Loss

Tilray Inc. was hit with a proposed investor class action in New York federal court Friday accusing the Canadian medical cannabis cultivation and distribution company of overstating the advantages of a...

Already a subscriber? Click here to view full article